Antiplatelet agents and proton pump inhibitors – personalizing treatment

References

• AdamsRJAlbersGAlbertsMJUpdate to the AHA/ASA Recommendations for the Prevention of Stroke in Patients With Stroke and Transient Ischemic AttackStroke20083951647165218322260
   PubMed Web of Science ®Google Scholar
• FDAInformation for Healthcare Professionals: Update to the labeling of Clopidogrel Bisulfate (marketed as Plavix) to alert healthcare professionals about a drug interaction with omeprazole (marketed as Prilosec and Prilosec OTC)2009 Accessed Nov 18, 2009
   Google Scholar
• RassenJAChoudhryNKAvornJSchneeweissSCardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary SyndromeCirculation2009120232322232919933932
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ CollaborationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ20023247329718611786451
   PubMed Web of Science ®Google Scholar
• ESPRIT Study GroupHalkesPHvan GijnJKappelleLJKoudstaalPJAlgraAAspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trialLancet200636795231665167316714187
   PubMed Web of Science ®Google Scholar
• DienerHCSaccoRLYusufSEffects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled studyLancet Neurol200871087588418757238
   PubMed Web of Science ®Google Scholar
• ChenZMJiangLXChenYPAddition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trialLancet200536694971607162116271642
   PubMed Web of Science ®Google Scholar
• YusufSZhaoFMehtaSREffects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationN Engl J Med2001345749450211519503
   PubMed Web of Science ®Google Scholar
• BeckerRCScheimanJDauermanHLManagement of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal ProceduresJ Am Coll Cardiol200954242261227619942393
   PubMed Web of Science ®Google Scholar
• KushnerFGHandMSmithSCJr2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesCatheter Cardiovasc Interv2009747E25E6819924773
   PubMed Web of Science ®Google Scholar
• PatelDMoonisMClinical implications of aspirin resistanceExpert Rev Cardiovasc Ther20075596997517867925
   PubMedGoogle Scholar
• KrasopoulosGBristerSJBeattieWSBuchananMRAspirin ‘resistance’ and risk of cardiovascular morbidity: systematic review and meta-analysisBMJ2008336763719519818202034
   PubMed Web of Science ®Google Scholar
• DerrySLokeYKRisk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysisBMJ200032172701183118711073508
   PubMed Web of Science ®Google Scholar
• AroraGSinghGTriadafilopoulosGProton Pump Inhibitors for Gastroduodenal Damage Related to Nonsteroidal Anti-inflammatory Drugs or Aspirin: Twelve Important Questions for Clinical PracticeClin Gastroenterol Hepatol20097772573519306941
   PubMed Web of Science ®Google Scholar
• LaiKCLamSKChuKMLansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin UseN Engl J Med2002346262033203812087138
   PubMed Web of Science ®Google Scholar
• IñarreaPEstevaFCornudellaRLanasAOmeprazole Does Not Interfere with the Antiplatelet Effect of Low-Dose Aspirin in ManScand J Gastroenterol20003524224610766315
   PubMed Web of Science ®Google Scholar
• DerendorfHVanderMaelenCPBricklRSMacGregorTREisertWDipyridamole Bioavailability in Subjects With Reduced Gastric AcidityJ Clin Pharmacol200545784585015951475
   PubMed Web of Science ®Google Scholar
• SaviPCombalbertJGaichCThe antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450–1AThromb Haemost19947223133177831671
   PubMed Web of Science ®Google Scholar
• SaviPPereilloJMUzabiagaMFIdentification and Biological Activity of the Active Metabolite of ClopidogrelThromb Haemost200084589189611127873
   PubMed Web of Science ®Google Scholar
• WeberAABraunMHohlfeldTSchwippertBTschöpeDSchrörKRecovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteersBr J Clin Pharmacol200152333333611560568
   PubMed Web of Science ®Google Scholar
• Ingelman-SundbergMSimSCGomezARodriguez-AntonaCInfluence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspectsPharmacol Ther2007116349652618001838
   PubMed Web of Science ®Google Scholar
• MegaJLCloseSLWiviottSDCytochrome P-450 Polymorphisms and Response to ClopidogrelN Engl J Med2009360435436219106084
   PubMed Web of Science ®Google Scholar
• ColletJPHulotJSPenaACytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyLancet2009373966030931719108880
   PubMed Web of Science ®Google Scholar
• ShuldinerARO’ConnellJRBlidenKPAssociation of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel TherapyJAMA2009302884985719706858
   PubMed Web of Science ®Google Scholar
• DestaZZhaoXShinJGFlockhartDAClinical Significance of the Cytochrome P450 2C19 Genetic PolymorphismClin Pharmacokinet2002411291395812222994
   PubMed Web of Science ®Google Scholar
• BhattDLScheimanJAbrahamNSACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsJ Am Coll Cardiol200852181502151719017521
   PubMed Web of Science ®Google Scholar
• LanasAGarcia-RodriguezLAArroyoMTEffect of Antisecretory Drugs and Nitrates on the Risk of Ulcer Bleeding Associated With Nonsteroidal Anti-Inflammatory Drugs, Antiplatelet Agents, and AnticoagulantsAm J Gastroenterol2007102350751517338735
   PubMed Web of Science ®Google Scholar
• Kwong MingFTiing LeongALean ChooBEdmund Jon DeonLProton Pump Inhibitors: Do Differences in Pharmacokinetics Translate into Differences in Clinical Outcomes?Clin Pharmacokinet2008471618076214
   PubMed Web of Science ®Google Scholar
• NorgardNBMathewsKDWallGCDrug-Drug Interaction Between Clopidogrel and the Proton Pump InhibitorsAnn Pharmacother20094371266127419470853
   PubMed Web of Science ®Google Scholar
• GilardMArnaudBGalGLAbgrallJFBoschatJInfluence of omeprazol on the antiplatelet action of clopidogrel associated to aspirinJ Thromb Haemost20064112508250916898956
   PubMed Web of Science ®Google Scholar
• GilardMArnaudBCornilyJCInfluence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin: The Randomized, Double-Blind OCLA (Omeprazole CLopidogrel Aspirin) StudyJ Am Coll Cardiol200851325626018206732
   PubMed Web of Science ®Google Scholar
• SmallDSFaridNAPayneCDEffects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and ClopidogrelJ Clin Pharmacol April 1, 2008200848447548418303127
   PubMed Web of Science ®Google Scholar
• Siller-MatulaJMSpielAOLangIMKreinerGChristGJilmaBEffects of pantoprazole and esomeprazole on platelet inhibition by clopidogrelAm Heart J200911571148.e1e5 Epub 2008 Nov 619081411
   PubMed Web of Science ®Google Scholar
• SibbingDMTanjaStegherrJuliaImpact of proton pump inhibitors on the antiplatelet effects of clopidogrelThromb Haemost2009101471471919350116
   PubMed Web of Science ®Google Scholar
• CuissettTFrereCQuiliciJComparison of Omeprazole and Pantoprazole Influence on a High 150-mg Clopidogrel Maintenance Dose: The PACA (Proton Pump Inhibitors And Clopidogrel Association) Prospective Randomized StudyJ Am Coll Cardiol200954131149115319761935
   PubMed Web of Science ®Google Scholar
• RayWAMurrayKTGriffinMROutcomes With Concurrent Use of Clopidogrel and Proton-Pump InhibitorsAnn Intern Med2010152633734520231564
   PubMed Web of Science ®Google Scholar
• O’DonoghueMLBraunwaldEAntmanEMPharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trialsLancet2009374969498999719726078
   PubMed Web of Science ®Google Scholar
• RamirezJFProton pump inhibitor and clopidogrel combination is not associated with adverse clinical outcomes after PCI: The NHLBI Dynamic RegistryPresented at: American College of Cardiology Session/i2 SummitMarch 29, 2009Orlando, FL http://www.tctmd.com/show.aspx?id=77266
   Google Scholar
• BhattDLCryerMMByronMDContantCFCOGENT: A prospective, randomized, placebo-controlled trial of omeprazole in patients receiving aspirin and clopidogrelTransvascular Cardiovascular Therapeutics Annual MeetingSept 2009
   Google Scholar
• DunnSPMacaulayTEBrennanDMAbstract 3999: Baseline Proton Pump Inhibitor Use is Associated with Increased Cardiovascular Events With and Without the Use of Clopidogrel in the CREDO TrialCirculation200811818_MeetingAbstractsS_1458
   Web of Science ®Google Scholar
• PezallaEDayDPulliadathIInitial Assessment of Clinical Impact of a Drug Interaction Between Clopidogrel and Proton Pump InhibitorsJ Am Coll Cardiol200852121038103918786491
   PubMed Web of Science ®Google Scholar
• JuurlinkDNGomesTKoDTA population-based study of the drug interaction between proton pump inhibitors and clopidogrelCMAJ 2009 Mar 312009180771371819176635
   PubMed Web of Science ®Google Scholar
• HoPMMaddoxTMWangLRisk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary SyndromeJAMA2009301993794419258584
   PubMed Web of Science ®Google Scholar
• StanekEJAubertREFlockhartDAA national study of the effect of individual proton pump inhibitors on cardiovascular outcomes in patients treated with clopidogrel following coronary stenting: The Clopidogrel Medco Outcomes Study2009 http://www.theheart.org/article/967075.do
   Google Scholar